Amlodipine/Atorvastatin (Caduet)
Caduet (Pfizer), a combination of the calcium-channel blocker amlodipine (Norvasc - Pfizer) and the HMG-CoA reductase inhibitor (statin) atorvastatin (Lipitor - Pfizer), is now available in the US. It was approved by the FDA for use in patients with indications for treatment with both amlodipine, which is used to treat hypertension and/or angina pectoris, and atorvastatin, which is used to treat dyslipidemia. The combination is bioequivalent to the 2 components taken separately....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Amlodipine/Atorvastatin (Caduet)
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1186
Article Code: 1186b
Date: July 5, 2004
Volume: 46
Page: 56
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1186
Article Code: 1186b
Date: July 5, 2004
Volume: 46
Page: 56
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)